Sign in
Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis
Journal article   Peer reviewed

Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis

Katherine M Clifford, Lisa D Hobson-Webb, Michael Benatar, Ted M Burns, Carolina Barnett, Nicholas J Silvestri, James F Howard, Jr, Amy Visser, Brian A Crum, Richard Nowak, …
Muscle & nerve, Vol.59(4), pp.404-410
2019-04
PMID: 30575980

Abstract

Humans Middle Aged Myasthenia Gravis - therapy Male Treatment Outcome Young Adult Rituximab - therapeutic use Thymectomy Immunoglobulins, Intravenous - therapeutic use Receptor Protein-Tyrosine Kinases - genetics Adolescent Age of Onset Adult Female Myasthenia Gravis - genetics Aged Retrospective Studies Child Prednisone - therapeutic use Cohort Studies Receptors, Cholinergic - genetics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.203 Neuromuscular Disorders
1.203.1325 Myasthenia Gravis
Web Of Science research areas
Clinical Neurology
Neurosciences
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details